Biochemical pathways of copper complexes: progress over the past 5 years
Siffeen Zehra1, Sartaj Tabassum1, Farukh Arjmand1
1Department of Chemistry, Aligarh Muslim University, Aligarh 202002, UP, India.
Drug Discovery Today
|January 24, 2021
Summary
Copper complexes show promise as potent anticancer drugs, offering biocompatibility and fewer side effects than traditional platinum drugs. Research highlights their multiple pathways for inhibiting cancer, paving the way for improved therapeutics.
Area of Science:
- Biochemistry
- Metallodrugs
- Cancer Biology
Background:
- Copper is an essential trace element crucial for metalloenzyme function.
- Copper complexes are emerging as potent non-platinum anticancer metallodrugs.
- These complexes offer advantages over cisplatin, including biocompatibility, higher potency, and a wider therapeutic window.
Purpose of the Study:
- To review recent advances in copper complexes as antitumor drug candidates.
- To explore the biochemical and pharmacological pathways of copper-based anticancer agents.
- To guide the development of more effective cancer therapeutics.
Main Methods:
- Literature review of studies published in the last 5 years.
- Analysis of biochemical mechanisms of copper's antitumor activity.
- Pharmacological evaluation of copper complexes in cancer models.
Main Results:
- Copper complexes demonstrate significant antitumor activity through multiple inhibitory pathways.
- Biocompatibility and reduced adverse effects are key advantages.
- Recent research has elucidated complex biochemical interactions and pharmacological profiles.
Conclusions:
- Copper complexes represent a promising class of lead anticancer drug candidates.
- Understanding their mechanisms of action is crucial for therapeutic development.
- Further research can lead to improved clinical outcomes in cancer treatment.
Related Concept Videos
00:56Extraction: Advanced Methods
797
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
797
01:29Amino Acid Biosynthetic Pathways
523
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
523
01:43Electron Transport Chain: Complex III and IV
8.6K
During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
8.6K
01:46Electron Transport Chain: Complex I and II
17.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
17.1K
01:19Phase II Reactions: Miscellaneous Conjugation Reactions
209
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
209
01:25Lipid Catabolism
535
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
535